Streetwise Reports Examines the Commercial Launch Planned for Schizophrenia Drug
24 janv. 2019 07h00 HE
|
Streetwise Reports Llc
SAN FRANCISCO, Jan. 24, 2019 (GLOBE NEWSWIRE) -- DURECT Corp. (DRRX:NASDAQ), a biopharmaceutical company, noted that Indivior Plc announced that it will launch in the U.S. its drug for the treatment...